$3.425
-0.095[-2.70%]
Last update: 1:13PM Get Real Time Here
Sutro Biopharma
(NASDAQ:STRO)Latest News for Sutro Biopharma Stock (NASDAQ:STRO)
Sutro Biopharma Stock (NASDAQ: STRO)
Categories: All
Tuesday, April 30, 2024
Wednesday, April 03, 2024
- Piper Sandler Reiterates Overweight on Sutro Biopharma, Lowers Price Target to $11Benzinga Newsdesk - Apr 3, 2024, 11:35AM
- Oppenheimer Maintains Outperform on Sutro Biopharma, Maintains $10 Price TargetBenzinga Newsdesk - Apr 3, 2024, 10:06AM
- Truist Securities Maintains Buy on Sutro Biopharma, Lowers Price Target to $18Benzinga Newsdesk - Apr 3, 2024, 9:32AM
- JMP Securities Reiterates Market Outperform on Sutro Biopharma, Maintains $17 Price TargetBenzinga Newsdesk - Apr 3, 2024, 8:23AM
Tuesday, April 02, 2024
- What's Going On With Sutro Biopharma (STRO) Stock?Henry Khederian - Apr 2, 2024, 12:46PM
- Sutro Biopharma Priced An Underwritten Offering Of 14.48M Shares At $5.18/Share, With Gross Proceeds Of Approximately $75MBenzinga Newsdesk - Apr 2, 2024, 6:22AM
- Ipsen And Sutro Biopharma Enter Exclusive Global Licensing Agreement For An ADC Targeting Solid TumorsBenzinga Newsdesk - Apr 2, 2024, 1:49AM
Thursday, March 28, 2024
- Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Mar 28, 2024, 2:08PM
- Sutro Biopharma shares are trading higher after Oppenheimer maintained its Outperform rating and $10 price target on the stock. The company recently reported 2023 financial results.Benzinga Newsdesk - Mar 28, 2024, 11:30AM
- REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Mar 28, 2024, 11:00AM
- Oppenheimer Maintains Outperform on Sutro Biopharma, Maintains $10 Price TargetBenzinga Newsdesk - Mar 28, 2024, 7:43AM
Wednesday, March 27, 2024
Tuesday, March 26, 2024
- Wedbush Maintains Outperform on Sutro Biopharma, Lowers Price Target to $8Benzinga Newsdesk - Mar 26, 2024, 9:40AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Mar 26, 2024, 9:05AM
- JMP Securities Reiterates Market Outperform on Sutro Biopharma, Maintains $17 Price TargetBenzinga Newsdesk - Mar 26, 2024, 8:35AM
- Sutro Biopharma shares are trading higher after the company reported FY23 financial results.Benzinga Newsdesk - Mar 26, 2024, 8:16AM
- HC Wainwright & Co. Maintains Buy on Sutro Biopharma, Lowers Price Target to $12Benzinga Newsdesk - Mar 26, 2024, 6:11AM
Monday, March 25, 2024
Thursday, January 04, 2024
Monday, December 11, 2023
Thursday, November 30, 2023
Tuesday, November 21, 2023
Wednesday, November 15, 2023
- Expert Ratings for Sutro BiopharmaBenzinga Insights - Nov 15, 2023, 11:00AM
- Piper Sandler Maintains Overweight on Sutro Biopharma, Lowers Price Target to $12-Report Released on 14th Nov 2023Benzinga Newsdesk - Nov 15, 2023, 10:38AM
- Piper Sandler Maintains Overweight on Sutro Biopharma, Lowers Price Target to $12Benzinga Newsdesk - Nov 15, 2023, 10:38AM
Tuesday, November 14, 2023
Monday, November 13, 2023
Thursday, November 09, 2023
Monday, October 23, 2023
Monday, October 16, 2023
Friday, October 06, 2023
- Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge UpsideVandana Singh - Oct 6, 2023, 2:05PM
- Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023Benzinga Insights - Oct 6, 2023, 11:00AM
- 5 Analysts Have This to Say About Sutro BiopharmaBenzinga Insights - Oct 6, 2023, 9:00AM
- Oppenheimer Initiates Coverage On Sutro Biopharma with Outperform Rating, Announces Price Target of $10Benzinga Newsdesk - Oct 6, 2023, 5:38AM
Thursday, September 21, 2023
Tuesday, September 19, 2023
Wednesday, September 06, 2023
Wednesday, August 30, 2023
Tuesday, August 29, 2023
Monday, August 14, 2023
Friday, August 11, 2023
- Stocks That Hit 52-Week Lows On FridayBenzinga Insights - Aug 11, 2023, 2:01PM
- Where Sutro Biopharma Stands With AnalystsBenzinga Insights - Aug 11, 2023, 2:00PM
- HC Wainwright & Co. Reiterates Buy on Sutro Biopharma, Maintains $16 Price TargetBenzinga Newsdesk - Aug 11, 2023, 12:58PM
- Wedbush Maintains Outperform on Sutro Biopharma, Lowers Price Target to $12Benzinga Newsdesk - Aug 11, 2023, 10:44AM